Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib is an effective and safe treatment for alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Low dose valproic acid treatment caused hair loss in a young patient.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

MK-5108 is safe and shows potential against tumors, especially alone.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.